Eva Martí BallesterosEva Martí Ballesteros

Eva María Marti Ballesteros

FACULTATIVO ESPECIALISTA HEMATOLOGÍA Y HEMOTERAPÍA
Hematología y Hemoterapiaes/especialidades/hematologia-hemoterapia
Ver más especialistas en Madridmadrid

es/cuadro-medico/hematologo

Datos destacados

  • Última publicación:
    Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).

Datos del profesional

Hospital Universitario Quirónsalud Madrid
FACULTATIVO ESPECIALISTA HEMATOLOGÍA Y HEMOTERAPÍA
Enero 2023 - Actualidad
Hospital Universitario Ruber Juan Bravo
FACULTATIVO ESPECIALISTA HEMATOLOGÍA Y HEMOTERAPÍA
Noviembre 2017 - Actualidad
Hospital Universitario Ruber Juan Bravo
FACULTATIVO ESPECIALISTA HEMATOLOGÍA Y HEMOTERAPÍA
Enero 2023 - Actualidad
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
Journal Article
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Observational Study, Journal Article
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
Case Reports, Letter, Research Support, Non-U.S. Govt